Spotlight Innovation has entered into a sponsored research agreement with Indiana University to develop safe and effective therapeutic options for the treatment of spinal muscular atrophy.
The partnership will seek ... Read more
Spotlight Innovation announced that it has acquired an exclusive, worldwide license to commercialize STL-182, an orally administered small molecule under investigation as a potential treatment for spinal muscular atrophy (SMA). ... Read more
Pin It on Pinterest